Reimbursement

Commercializing a new medical device involves navigating a complex landscape of regulatory, payer and provider considerations. For some devices, one critical component of this process is the review by the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), which can…

Understanding coding and coverage mechanisms are essential to developing a reimbursement strategy for a new medical technology. These Q&As address the differences between coding and coverage. My device has been cleared by the FDA. Does the regulatory approval guarantee coverage…